Application

15333148 · 2-ARYL- AND 2-HETEROARYL-SUBSTITUTED 2-PYRIDAZIN-3(2H)-ONE COMPOUNDS AS INHIBITORS OF FGFR TYROSINE KINASES

Filed 2016-10-24 · Granted · Patent 10208024 (2019-02-19) The official file ↗The patent and its PDF ↗ · Art unit 1624 · Examiner Ebenezer O Sackey Easy · CPC C07D 403/14 · Array BioPharma, Inc. · Eli Lilly and Company

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

9.0 mo

to disposition 27.9 mo

Statutes raised

112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.